Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455

Yao Yu Hsieh; Tsui Chin Huang; Hsiang Ling Lo; Jyun Yan Jhan; Shui Tein Chen; Pei Ming Yang

ArticleOPEN ACCESS

Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455

Oncotarget

DOI: 10.18632/oncotarget.26019

0Citations

6Readers

Abstract

This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,2,5 5 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Cite

CITATION STYLE

APA

Hsieh, Y. Y., Huang, T. C., Lo, H. L., Jhan, J. Y., Chen, S. T., & Yang, P. M. (2018, August 17). Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.26019

Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455

Abstract

Cite

Register to see more suggestions